Adneuris Therapeutics has granted Maruishi Pharmaceutical exclusive rights to develop [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

AC Immune has outlined a series of clinical milestones expected [...]

ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

A new AI model has generated patient-specific radiation dose-rate maps [...]

Boehringer Ingelheim’s Jascayd has received European marketing authorisation for idiopathic [...]

The National Health Council has launched a Detroit pilot campaign [...]

Enzene has launched a biomanufacturing model designed to help governments [...]

Vaximm AG has completed analysis of two clinical studies evaluating [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]